UBS Adjusts ArcBest Price Target to $126 From $150, Maintains Neutral Rating

ArcBest (ARCB) has an average rating of outperform and price targets ranging from $110 to $180, according to analysts polled by Capital IQ. Price: 110.02, Change: -0.89, Percent Change: -0.80

MT Newswires00:15

ArcBest Is Maintained at Overweight by JP Morgan

ArcBest Is Maintained at Overweight by JP Morgan

Dow JonesMay 1 23:20

ArcBest Price Target Cut to $145.00/Share From $164.00 by JP Morgan

ArcBest Price Target Cut to $145.00/Share From $164.00 by JP Morgan

Dow JonesMay 1 23:20

JP Morgan Maintains Overweight on ArcBest, Lowers Price Target to $145

JP Morgan analyst Brian Ossenbeck maintains ArcBest (NASDAQ:ARCB) with a Overweight and lowers the price target from $164 to $145.

BenzingaMay 1 23:10

ArcBest Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/01/2024 31.93% JP Morgan $164 → $145 Maintains Overweight 04/15/2024 30.11% B of A Securities $141 → $1

BenzingaMay 1 23:09

ArcBest Underperform Rating: Deterioration in Margins and Market Position

TipRanksMay 1 18:46